China guideline for diagnosis and comprehensive treatment of colorectal liver metastases (version 2020).
10.3760/cma.j.cn.441530-20201225-00680
- VernacularTitle:中国结直肠癌肝转移诊断和综合治疗指南（V2020）
- Collective Name:Chinese College of Surgeons;Section of Gastrointestinal Surgery, Branch of Surgery, Chinese Medical Association;Section of Colorectal Surgery, Branch of Surgery,Chinese Medical Association;Section of Colorectal Oncology, Oncology Branch, Chinese Medical Association;Colorectal Cancer Professional Committee, Chinese Anti-Cancer Association;Colorectal Cancer Professional Committee, Chinese Medical Doctor Association;Colorectal Cancer Expert Committee, Chinese Society of Clinical Oncology;Chinese Society of Colon and Rectal Surgeons, Chinese College of Surgeons, Chinese Medical Doctor Association;Metastasis Research Committee, Anorectal Branch of Chinese Medical Doctor Association;Colorectal Liver Metastases Professional Committee, China International Exchange and Promotive Association for Medical and Health Care
- Publication Type:Practice Guideline
- Keywords:
Colorectal neoplasms;
Comprehensive treatment;
Diagnosis;
Guideline;
Liver metastases
- MeSH:
China;
Colorectal Neoplasms/therapy*;
Combined Modality Therapy;
Humans;
Liver Neoplasms/therapy*;
Patient Care Team
- From:
Chinese Journal of Gastrointestinal Surgery
2021;24(1):1-13
- CountryChina
- Language:Chinese
-
Abstract:
The liver is the most common anatomical site for hematogenous metastases of colorectal cancer, and colorectal liver metastasis is one of the most difficult and challenging situations in the treatment of colorectal cancer. In order to improve the diagnosis and comprehensive treatment in China, the Guidelines have been edited and revised for several times since 2008, including the overall evaluation, personalized treatment goals and comprehensive treatments, to prevent the occurrence of liver metastases, improve the resection rate of liver metastases and survival. The revised Guideline version 2020 includes the diagnosis and follow-up, prevention, multidisciplinary team (MDT), surgery and local ablative treatment, neoadjuvant and adjuvant therapy, and comprehensive treatment, with state-of-the-art experience and findings, detailed content, and strong operability.
